We confirmed the loss of B2m on MC38 cell surface by flow cytometry (Fig. 1i), and then implanted B2m-deficient tumors into Cd4-Cre+Lsd1f/f mice or littermate controls to monitor tumor growth. This evidence concerns the gene B2M and neoplasm.